| abstract |
The present invention relates to a red ginseng acid polysaccharide (RGAP) having an anticancer immunomodulatory effect isolated from red ginseng and an anticancer immunomodulating pharmaceutical composition containing the same as an active ingredient, more specifically, extracting, dialysis and precipitation from red ginseng Glucuronic acid, 41.6-60.0 mol%, galacturonic acid 2.7-7.5 mol%, glucose 18.8-33.4 mol%, arabinose 1.1-2.1 The present invention relates to a novel acidic polysaccharide having an anticancer immunomodulatory effect having a sugar composition composed of mol% and having a molecular weight of 12,000 to 450,000, and an anticancer immunomodulating pharmaceutical composition containing the same as an active ingredient. Acidic polysaccharide of the present invention exhibits anti-cancer immunomodulatory effect, cancer cell transplant life extension effect and anti-tumor effect showing cancer cell death effect, so that the pharmaceutical composition containing it is useful as an anti-cancer immunomodulator with anticancer activity by immunomodulation Can be used. |